No changes have been made to clinical guidance in the 2024 Recommendations for Preventive Pediatric Health Care (Periodicity Schedule), but footnotes have been updated to reflect new and revised policy and research on newborn follow-up visit, substance use assessment, body mass index (BMI) screening and other topics.
The AAP approved the 2024 schedule, which outlines recommended screenings and assessments for patients from birth to age 21.
The following changes have been made to the footnotes:
- Footnote 4 regarding a newborn’s 3-5 day visit links to the updated AAP policy statement Breastfeeding and the Use of Human Milk.
- Footnote 5 regarding BMI screening links to the AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity.
- Footnote 14 on behavioral/social/emotional screening adds a link to recommendations from the U.S. Preventive Services Task Force titled Anxiety in Children and Adolescents: Screening.
- Footnote 15 on tobacco, alcohol or drug use assessment adds links to guidance from the Centers for Disease Control and Prevention and the National Institute on Drug Abuse regarding recommending or prescribing naloxone.
- Footnote 21 on newborn bilirubin screening adds a link to the AAP Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
- Footnotes 35 and 36 on oral health have been updated with a link to the revised AAP clinical report Maintaining and Improving the Oral Health of Young Children.